Vimab Group AB (publ) (OM:VIMAB) signed letter of intent to acquire Solomon Oy for â¬2.3 million on June 20, 2023. Initial purchase price of â¬1.8 million includes â¬0.5 million in cash, â¬1.3 million in Vimab shares. Signing of share transfer agreement is planned for Q3 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 SEK | -1.16% |
|
-9.09% | -4.06% |
05-08 | Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Vimab Group AB (OM:VIMAB) agreed to acquire Tranfoten Aktiebolag. | CI |
1st Jan change | Capi. | |
---|---|---|
-4.06% | 18.08M | |
-34.56% | 3.08B | |
+10.72% | 2.84B | |
+6.90% | 1.71B | |
-19.97% | 943M | |
+3.26% | 697M | |
-10.57% | 661M | |
-4.61% | 595M | |
-13.62% | 572M | |
-4.36% | 561M |
- Stock Market
- Equities
- VIMAB Stock
- News Vimab Group AB
- Vimab Group AB (OM: VIMAB) signed letter of intent to acquire Solomon Oy for €2.3 million.